Epstein Secrets

psala in Sweden, where one of the others is Robert Califf, the current Commissioner of the FDA (the other is Marcia McNutt, the current President of the National Academy of Sciences), so I should get the chance to bend his ear at various meals (a former commissioner — under Bush II — was a partial PhD student of mine when he wa

r you around on the weekend in cambridge.? On Wed, Dec 7, 2016 at 1:10 PM, Donald Rubin < wrote: OK. I'll get back to you after I make contact with Adriaan again, and my plans settle a bit. On Dec 7, 2016, at 10:38 AM, jeffrey E. <jeevacation®gmail.com> wrote: three way skype for 3. and yes 1 face to f

effects is the following. This morning I just had an exchange of emails with the CEO of EB, whom I've known and worked with for about three years, Adriaan Tuiten. He wrote that FDA has agreed with EB's proposal for more trials, and the EB board of directors just approved the issuance of about 12 million Euros

psala in Sweden, where one of the others is =obert Califf, the current Commissioner of the FDA (the other is Marcia McN=tt, the current President of the National Academy of Sciences), so I shoul= get the chance to bend his ear at various meals (a former commissioner =E2401, under Bush II — was a partial PhD student of mine when

ar you around on the weekend in cambridg=.? On Wed, Dec 7, 2016 at 1:10 PM, Donald Rubin wrote: OK. I'll get back to you after I make contact with=Adriaan again, and my plans settle a bit. wrote: wrote: On Dec 7, 2016, at 10:38 AM, jef=rey E. <[email protected] <mailto:[email protected]» thr

eff=cts is the following. This morning I just had an exchange of emails =ith the CEO of EB, whom I've known and worked with for about three=years, Adriaan Tuiten. He wrote that FDA has agreed with EB'= proposal for more trials, and the EB board of directors just approved the=issuance of about 12 million Euros

sala in Sweden, where one of the others is Ro=ert Califf, the current Commissioner of the FDA (the other is Marcia McNut=, the current President of the National Academy of Sciences), so I should =et the chance to bend his ear at various meals (a former commissioner Q=80Q under Bush II — was a partial PhD student of mine when he

topic of placebo respon=e, which are still not that wonderfully written. =. If interested in exploring investing in EB, I can put you in touch=with Adriaan, who lives in Amsterdam. Are any of =hese appealing? I prefer 1 to 2. I think a face to face versio= of 3 could be arranged either here or there. l

o effects is the following. This morning I just had an =xchange of emails with the CEO of EB, whom I've known and worked w=th for about three years, Adriaan Tuiten. He wrote that FDA has agre=d with EB's proposal for more trials, and the EB board of director= just approved the issuance of about 12 million Euro